HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 1 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,000 | -50.0% | 18,640 | 0.0% | 0.00% | – |
| Q2 2020 | $14,000 | +100.0% | 18,640 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -50.0% | 18,640 | 0.0% | 0.00% | – |
| Q4 2019 | $14,000 | +7.7% | 18,640 | 0.0% | 0.00% | – |
| Q3 2019 | $13,000 | -58.1% | 18,640 | 0.0% | 0.00% | – |
| Q2 2019 | $31,000 | -34.0% | 18,640 | 0.0% | 0.00% | – |
| Q1 2019 | $47,000 | – | 18,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 466 | $2,000 | 0.00% |